SCHEMBL28281136

SCHEMBL28281136

COc1cccc(Cc2ccc3ncncc3c2)c1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 4/20 0.64
CYP1A2 P05177 7/20 0.49
CYP3A4 P08684 7/20 0.49
CYP2C9 P11712 7/20 0.49
CYP2C19 P33261 7/20 0.49
USP2 O75604 5/20 0.49
ALDH1A1 P00352 5/20 0.49
LMNA P02545 5/20 0.49
CYP2D6 P10635 4/20 0.49
TSHR P16473 3/20 0.49
MEN1 O00255 1/20 0.49
KMT2A Q03164 1/20 0.49
CLK4 Q9HAZ1 1/20 0.49
DHFR P00374 1/20 0.49
LTA4H P09960 2/20 0.46
KIT P10721 1/20 0.44
MAPT P10636 2/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
HTT P42858 1/20 0.44
MAPK1 P28482 4/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3372138 0.79 EGFR (1.00) EGFRCYP1A2CYP3A4CYP2C9ALDH1A1
SCHEMBL28292983 0.79 CYP2D6 (0.47) EGFRCYP1A2CYP3A4CYP2C9CYP2C19
Hydrochloric Acid SCHEMBL28032872 0.78 EGFR (0.96) EGFRCYP1A2CYP3A4CYP2C9ALDH1A1
SCHEMBL28173445 0.76 LTA4H (0.51) KMT2ADHFRLTA4HMAOBCHRM2
SCHEMBL2099512 0.75 CHRM2 (0.66) LTA4HMAOBCHRM2CHRM1CHRM3
SCHEMBL28119906 0.75 MAP4K4 (0.66) EGFRCYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL28264115 0.74 EGFR (0.49) EGFRCYP1A2CYP3A4CYP2C9CYP2C19
Biphenyl SCHEMBL28023494 0.73 EGFR (0.79) EGFRCYP1A2CYP3A4CYP2C19USP2
SCHEMBL30918007 0.73 EGFR (0.55) EGFRCYP1A2SMN1; SMN2FGFR4
SCHEMBL9776814 0.73 EGFR (0.55) EGFRCYP1A2SMN1; SMN2FGFR4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-106317026-B A kind of compound being able to suppress ErbB/HDAC and preparation method thereof includes its pharmaceutical composition and application thereof 清华大学深圳研究生院 2019-03-22 CN disclosed